Skip to content

Efficacy and Tolerance of Reginald Men Zeus Lip Serum/Balm

A Clinical study to Evaluate the Efficacy and Tolerance of Reginald Men Zeus Lip Serum/Balm on Human Lips - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094699
Enrollment
32
Registered
2025-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Reginald Men Zeus Lip Serum/Balm: Test Product: Reginald Men Zeus Lip Serum/Balm Dose: Gently use the Reginald men Zeus Lip Serum/Balm twice a day for 4 weeks. Route of Ad

Sponsors

Btm Ventures Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Gender: Male and Female with age 18-45 (80:20) 2)Presence of visible lip dryness, dullness or pigmentation. 3)Subjects willing to give written informed consent 4)Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 5. Signed informed consent form

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing mothers 2. Current dermatological treatments on the lips. 3. Active cold sores, infections, open wounds, or trauma to the lips. 4.Tolerance rating included in the past-treatment questionnaire. 5.volunteers to report and discomfort or adverse events during the study period 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 7.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)

Design outcomes

Primary

MeasureTime frame
1. Change in hydration 2. Change in Melanin 3. DSLR imaging 4. Visual Grading 5. Dermascope imagingTimepoint: At t0, t30min, t28days

Secondary

MeasureTime frame
SGATimepoint: t28days

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026